Clinical Trials
Emmes acquires VaxTRIALS
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical inn...
October 06, 2023 | News
FDA Grants Orphan Drug Status to GC Biopharma's Thrombocytopenic Purpura Drug in South Korea
When designated as an orphan drug, there are incentives such as tax credits for clinical development costs and exemptions from PDUFA user fees Initial Pedi...
October 06, 2023 | News
Everest Medicines' Partner Calliditas Shares NefIgArd Phase 3 Trial Data at ISIN Tokyo 2023
"The positive findings from biomarker and patient subgroup analyses from the Phase 3 NefIgArd study highlights that Nefecon® treatment results in ...
October 05, 2023 | News
Australia's First Cu-67 SAR-Bombesin Prostate Cancer Trial Patient Treated
COMBAT, which derives from "Copper-67 SAR-Bombesin in metastatic castrate resistant prostate cancer (NCT05633160)1 is a dose escalation and co...
October 04, 2023 | News
Akeso and RemeGen Team Up for Gastric Cancer Therapy Study
On September 28, 2023, Akeso (9926.HK) announced that its subsidiary, Akeso Pharma, will collaborate with RemeGen (Yantai) Co., Ltd. (688331.SH/0...
October 02, 2023 | News
Bionomics Reports Positive Phase 2b Results for BNC210 in Post-Traumatic Stress Disorder Trial
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. St...
September 29, 2023 | News
Hong Kong's Akeso Receives FDA IND Clearance for AK117 in MDS Combo with Azacitidine
The upcoming study, known as a randomized, double-blind, global multi-center Phase II study, is set to be conducted in the United States. Based on th...
September 29, 2023 | News
Mabwell Starts Phase Ib/II Trial for Nectin-4 ADC with PD-1 Inhibitor
The clinical trial (CTR20232677) is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetic profile of 9MW2821 in combination with ...
September 29, 2023 | News
OBiO Launches GMP Facility Intelli-M for Rapid Delivery of Innovative Therapies
The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...
September 28, 2023 | News
Kivo launches unified platform offering best-in-class collaboration and compliance solution
Kivo GO is a new, unified platform for emerging life sciences companies who need to manage documents and processes across their Regulatory, Clinical and ...
September 27, 2023 | News
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design
Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design...
September 27, 2023 | News
Ascletis Completes Enrollment for Glioblastoma Treatment Trial
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the completion of enrollment of 120 patients in the Phase III registration clinical trial of ...
September 27, 2023 | News
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology
"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...
September 26, 2023 | News
Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031
Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to disco...
September 22, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
